The IGF-2 locus shows a loss of imprinting in both ERMS and ARMS tumors, and the expression of PAX3-FKHR has been demonstrated to upregulate IGF-2 and activate IGF pathway in ARMS [69]. The gene discussed is IGF2; the disease is alveolar rhabdomyosarcoma.